# Allergan Aesthetics completes acquisition of Soliton

Allergan Aesthetics, an AbbVie company, completed its acquisition of Soliton, Inc., adding the RESONIC device for cellulite treatment to its body contouring portfolio.

- Type: Acquisition
- Announced: 2021-12-16
- Where: United States
- Status: completed
- Products: RESONIC device for cellulite treatment, tattoo removal device
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [AbbVie](https://endata.com/companies/29401.md) (investor)
- [Allergan Aesthetics](https://endata.com/companies/55003.md) (acquirer)
- [Soliton](https://endata.com/companies/55004.md) (target)

## Sources

- [prnewswire.com](https://www.prnewswire.com/news-releases/allergan-aesthetics-completes-acquisition-of-soliton-301446558.html), 2021-12-16: "Allergan Aesthetics, an AbbVie company, today announced the successful completion of its acquisition of Soliton, Inc."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.
